Sandoz, a global leader in generic and biosimilar medicines, has appointed Dragos Toma as Country Head for Egypt and Libya. With more than 21 years in the pharmaceutical industry, including over 13 years at Sandoz, he has extensive experience in business leadership, healthcare policy and expanding patient access to medicines.
Dragos Toma takes on the role as Sandoz builds on its established position in Egypt, where the company leads in biosimilars, offers a broad portfolio of generic and essential medicines, and continues to advance local manufacturing and technology transfer.
Most recently, he headed the Biosimilars and Prescription Medicines Business Unit at Sandoz Romania. He also served as Interim Country Head in Romania. His experience includes engagement in national healthcare policy discussions on biosimilar prescribing, uptake and patient access.
Since joining Sandoz in 2013, Dragos Toma has held leadership positions across oncology, transplantation, immunology, biosimilars and prescription products, as well as over the counter medicines. He began his pharmaceutical career with Menarini Group in 2004, followed by Ranbaxy. He holds a bachelor’s degrees in law and has pursued a postgraduate business education through the Open University Business School. He is also a proud graduate of the Sandoz “General Management Academy” program at HEC in Paris. His professional interests include talent development, collaborative leadership and improving access to medicines.
Commenting on his appointment, Dragos Toma, Country Head of Sandoz Egypt and Libya, said:
“Egypt and Libya offer important opportunities to build on Sandoz’s established presence and partnerships. I look forward to working with our teams, authorities, healthcare professionals and stakeholders to strengthen local capabilities and help more patients access the medicines they need.”
